Renocell Biotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Renocell Biotech General Information

Description

Researcher and manufacturer of drugs intended to serve the pharmaceutical industry. The company offers cell injections, mesenchymal stem cell products, biologics, regenerative medicine therapies, drug candidates, and clinical trial products, enabling healthcare providers to treat systemic sclerosis through immune regulation and anti-fibrosis technology.

Contact Information

Website
www.rybiotech.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 4, Ruihong Zhihuiyuan
  • Number 2289, Tianyuan East Road, Jiangning District
  • Nanjing, Jiangsu 210000
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech
Corporate Office
  • 3rd Floor, Building 4, Ruihong Zhihuiyuan
  • Number 2289, Tianyuan East Road, Jiangning District
  • Nanjing, Jiangsu 210000
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renocell Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 15-Jul-2026 Completed Generating Revenue
3. Early Stage VC (Series A1) 28-Feb-2025 Completed Generating Revenue
2. Early Stage VC 02-Apr-2024 Completed Generating Revenue
1. Seed Round 10-Dec-2020 Completed Startup
To view Renocell Biotech’s complete valuation and funding history, request access »

Renocell Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nanjing Innovation Capital Group Venture Capital Minority
Zijin Hi-Tech Venture Capital Venture Capital Minority
New Film Private Equity Fund Management Growth/Expansion Minority
Nanjing Xingong Emerging Industry Investment Management Growth/Expansion Minority
Zhilai Investment Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Renocell Biotech FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process